CIK: 0001791468
Total reported value
$252.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Stock-Other | 25.42% | — | -4.20% | ||
| 2 | PLRX | Pliant Therapeutics INC | Stock-Other | 19.15% | — | +9.75% | |
| 3 | CGEM | Cullinan Therapeutics INC | Stock-Other | 11.18% | — | +6.42% | |
| 4 | RPTX | Repare Therapeutics INC | Stock-Other | 10.01% | — | +15.98% | |
| 5 | ✓ | Vectivbio Holding | Stock-Other | 6.65% | — | +8.92% | |
| 6 | ✓ | Stock-Other | 4.08% | — | -9.17% | ||
| 7 | LRMR | Larimar Therapeutics INC | Stock-Other | 2.94% | — | +125.40% | |
| 8 | ✓ | Akouos INC | Stock-Other | 2.34% | — | +54.09% | |
| 9 | TSVT* | 2seventy Bio INC | Stock-Other | 2.07% | — | -35.31% | |
| 10 | KROS | Keros Therapeutics INC | Stock-Other | 2.03% | — | +93.59% | |
| 11 | CMPX | Compass Therapeutics INC | Stock-Other | 1.73% | — | — | |
| 12 | OHI | Omega Healthcare Investors, Inc. | Stock-Real Estate | 1.54% | — | — | |
| 13 | ✓ | Inozyme Pharma INC | Stock-Other | 1.44% | — | -1.85% | |
| 14 | ✓ | Stock-Other | 1.28% | — | +22.34% | ||
| 15 | ✓ | Ikena Oncology INC | Stock-Other | 1.16% | — | +11.31% | |
| 16 | GTHXEUR | G1 Therapeutics INC | Stock-Other | 1.09% | — | -57.78% | |
| 17 | ORTXUSD | Orchard Therapeutics PLC | Stock-Other | 1.07% | — | +50.49% | |
| 18 | CLDNEUR | Eiger Biopharmaceuticals INC | Stock-Other | 0.92% | — | +111.58% | |
| 19 | ✓ | Freeline Therapeutics Hldgs | Stock-Other | 0.91% | — | -0.99% | |
| 20 | ✓ | Rallybio CORP | Stock-Other | 0.76% | — | — | |
| 21 | ✓ | Oncorus INC | Stock-Other | 0.54% | — | — | |
| 22 | CRVS | Corvus Pharmaceuticals INC | Stock-Other | 0.52% | — | +7.69% | |
| 23 | OVID | Ovid Therapeutics INC | Stock-Other | 0.43% | — | — | |
| 24 | NKTX | Nkarta INC | Stock-Other | 0.42% | — | -67.15% | |
| 25 | LABDUSD | Drx Dly S&p Biotech Bear 3x | ETF-Tech | 0.32% | — | — |